Filters: Author is Salazar, R [Clear All Filters]
Clinicopathological risk factors of Stage II colon cancer: results of a prospective study. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2013;15(4):414-22.
Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis. 2012;27(2):169-76.
Hepatic carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis: nonresistant cells die by nonapoptotic cell death. Neoplasia (New York, N.Y.). 2011;13(10):931-46.
Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays. Molecular & cellular proteomics : MCP. 2011;10(3):M110.001784.
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(1):17-24.
Gene expression differences between colon and rectum tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011;17(23):7303-12.